Create Account | Sign In: Author or Forum

Search Symptoms

JOURNAL UPDATE

Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy

December 09, 2022. 5:01 PM CST.

Viral rebound uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality

By Elana Gotkine HealthDay Reporter Read article

OTHER JOURNAL ARTICLES

COVID-19 Vaccine Prevents Against Reinfection

December 07, 2022

Findings show protection for all variant periods


SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients

December 07, 2022

SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin


HIV Care Services Resilient During COVID-19 Pandemic

December 05, 2022

Decrease seen in HIV tests performed, persons prescribed PrEP, HIV diagnoses in quarter 2 of 2020, but partial rebound observed in Q3


41.6 Percent of Adults Have Serology Indicative of Past COVID-19 Infection

December 05, 2022

25.5 percent of those whose serology indicated past infection reported not having been vaccinated, with higher rates seen in young, Black adults


Dynamically Updating Models Can Improve Prediction of COVID-19 Survival

December 05, 2022

Drift in model calibration performance was detected immediately, with minor fluctuations in discrimination


Herpes Zoster Linked to Increased Risk for Cardiovascular Disease Events

December 02, 2022

Long-term risks for stroke and coronary heart disease increased for individuals with history of herpes zoster versus those with no history of herpes zoster


Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization

December 02, 2022

Posthospitalization prevalence of residual lung abnormalities estimated at 11.7 percent in sensitivity analyses


PTSD, Psychiatric Disorders Tied to Higher Risk for Severe COVID-19 Outcomes

December 02, 2022

Findings seen even when accounting for sociodemographic factors, comorbidities, and smoking


Overactive Bladder Common in Postacute COVID-19 Syndrome

November 30, 2022

COVID-19 may lead to new or worsening urinary symptoms in men and women


Temporal Improvement Seen in Standard of Care for Hospitalized COVID-19 Patients

November 30, 2022

Outcomes improved from Adaptive COVID-19 Treatment Trial-2 to ACTT-3, although potential explanatory factors were similar


Increase Seen in Years of Life Lost Per COVID-19 Death in 2021

November 29, 2022

YLL increased 35.7 percent per COVID-19 death in 2021 versus 2020 as median age of COVID-19 deaths decreased


Medical Masks Similar to N95 Respirators for Preventing COVID-19

November 29, 2022

No significant difference seen with medical masks versus N95 respirators for health care personnel providing care to COVID-19 patients


Geographic Distribution of Dimorphic Mycoses Expanding in U.S.

November 29, 2022

Diagnosis and testing should be considered in patients with suggestive illness in regions that are hyperendemic for dimorphic mycoses


Studies Compare Various Treatments for COVID-19

November 28, 2022

Sotrovimab effective compared with molnupiravir; second study shows no effect for angiotensin receptor blockers in terms of illness severity


Asthma Exacerbations Up After Relaxation of COVID-19 Restrictions

November 28, 2022

Relaxation of restrictions coincided with increasing incidence of COVID-19, non-COVID-19 ARI, severe asthma exacerbations